Antibody light-chain-restricted recognition of the site of immune pressure in the RV144 HIV-1 vaccine trial is phylogenetically conserved.
about
Immune correlates of vaccine protection against HIV-1 acquisitionHigh-Throughput Sequencing-Based Immune Repertoire Study during Infectious DiseaseVaccine Elicitation of High Mannose-Dependent Neutralizing Antibodies against the V3-Glycan Broadly Neutralizing Epitope in Nonhuman PrimatesPentavalent HIV-1 vaccine protects against simian-human immunodeficiency virus challenge.HIV-1 VACCINES. Diversion of HIV-1 vaccine-induced immunity by gp41-microbiota cross-reactive antibodies.Rationally Targeted Mutations at the V1V2 Domain of the HIV-1 Envelope to Augment Virus Neutralization by Anti-V1V2 Monoclonal Antibodies.Vaccine-Induced Linear Epitope-Specific Antibodies to Simian Immunodeficiency Virus SIVmac239 Envelope Are Distinct from Those Induced to the Human Immunodeficiency Virus Type 1 Envelope in Nonhuman Primates.Rapid Development of gp120-Focused Neutralizing B Cell Responses during Acute Simian Immunodeficiency Virus Infection of African Green Monkeys.λ Light Chain Bias Associated With Enhanced Binding and Function of Anti-HIV Env Glycoprotein Antibodies.Structural Constraints of Vaccine-Induced Tier-2 Autologous HIV Neutralizing Antibodies Targeting the Receptor-Binding Site.Antibodies Elicited by Multiple Envelope Glycoprotein Immunogens in Primates Neutralize Primary Human Immunodeficiency Viruses (HIV-1) Sensitized by CD4-Mimetic Compounds.A Therapeutic Antibody for Cancer, Derived from Single Human B Cells.Envelope-specific B-cell populations in African green monkeys chronically infected with simian immunodeficiency virusInitiation of immune tolerance-controlled HIV gp41 neutralizing B cell lineagesAmino Acid Changes in the HIV-1 gp41 Membrane Proximal Region Control Virus Neutralization Sensitivity.Tissue memory B cell repertoire analysis after ALVAC/AIDSVAX B/E gp120 immunization of rhesus macaques.Immunization with an SIV-based IDLV Expressing HIV-1 Env 1086 Clade C Elicits Durable Humoral and Cellular Responses in Rhesus Macaques.HIV DNA-Adenovirus Multiclade Envelope Vaccine Induces Gp41 Antibody Immunodominance in Rhesus Macaques.Genetic and structural analyses of affinity maturation in the humoral response to HIV-1.Mimicry of an HIV broadly neutralizing antibody epitope with a synthetic glycopeptide.Immunodominance of Antibody Recognition of the HIV Envelope V2 Region in Ig-Humanized Mice.HIV-1 Envelope Mimicry of Host Enzyme Kynureninase Does Not Disrupt Tryptophan Metabolism.Short Communication: Small-Molecule CD4 Mimetics Sensitize HIV-1-Infected Cells to Antibody-Dependent Cellular Cytotoxicity by Antibodies Elicited by Multiple Envelope Glycoprotein Immunogens in Nonhuman Primates.Structural analysis of the unmutated ancestor of the HIV-1 envelope V2 region antibody CH58 isolated from an RV144 vaccine efficacy trial vaccinee.Origins of a Vaccine-Induced, Human Anti-HIV-1 Antibody.Structure and Diversity of the Rhesus Macaque Immunoglobulin Loci through Multiple De Novo Genome Assemblies.A murine Ig light chain transgene reveals IGKV3 gene contributions to anti-collagen types IV and II specificities.Common helical V1V2 conformations of HIV-1 Envelope expose the α4β7 binding site on intact virions
P2860
Q26778573-C585B8FF-3B58-4755-A2A6-A0681F6A342BQ28068214-8C62825A-AA05-4634-9025-C26098AD1ED1Q33612459-AB38EF89-AE83-43FA-A91A-CDEDC645262BQ33804531-749F4874-5752-42A1-85AE-FD52F651F36CQ35728947-AAFF49B6-BCD2-4FC5-8486-C3B31109F68BQ35817106-03D0F104-108F-47E7-B507-7CBEDAEDAD19Q35914306-10A7562B-B589-44EB-8E5B-C921DE36B863Q35973587-B79D4DBA-0F21-47D0-A69F-AD91CC9D783CQ36365309-E9B02879-FDB7-4FE0-B99C-F6050B1005BAQ36446733-3CE42324-F3E5-4D4C-ADB4-B61E26B9DD8DQ36878885-86ECF235-365A-4771-B8F8-92B5685ECFBDQ36913660-FE3A52A1-A08D-456B-8C20-F0CCA645FB79Q37072545-F72892A8-B1D9-447C-A53C-BD42D0E95A95Q37221575-CA8D6106-F5EA-4BF4-A516-F08D55631F59Q37363517-724B55FF-2E5C-45CF-B7D7-9504CC2B9F61Q37469197-2B9653AF-3873-469E-82C4-839280163630Q37499531-F466D3E4-0A97-4602-9D92-CB2DDC0AF36BQ38631751-90306068-84CF-4F37-9F6E-16A74C39B90FQ38992744-3D578205-E335-4DD1-90EC-298198C71AAEQ40290511-3E59B307-2202-4DE3-8D40-3B369635FDCAQ40409324-1C53C45B-DB28-4D9D-BB7E-BE5352D0E9E3Q40449984-F5F807F6-E4EA-49F0-88BC-F9DEC7A85282Q40450993-F5521F8A-D09D-4E6C-9E86-C67A61707F43Q40626878-8EEA446D-46BB-4F54-9B23-EECD2784BDA2Q41470106-5AA1350A-F669-4C7F-8D42-FF7C51C9B941Q47161892-E506611D-EDDA-421B-AB34-AD5E6528F531Q47833098-3548475B-6685-4108-A7C2-F26035B8C972Q58115616-AEE25235-EBF2-4581-9324-98094C671C37
P2860
Antibody light-chain-restricted recognition of the site of immune pressure in the RV144 HIV-1 vaccine trial is phylogenetically conserved.
description
2014 nî lūn-bûn
@nan
2014 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Antibody light-chain-restricte ...... is phylogenetically conserved.
@ast
Antibody light-chain-restricte ...... is phylogenetically conserved.
@en
type
label
Antibody light-chain-restricte ...... is phylogenetically conserved.
@ast
Antibody light-chain-restricte ...... is phylogenetically conserved.
@en
prefLabel
Antibody light-chain-restricte ...... is phylogenetically conserved.
@ast
Antibody light-chain-restricte ...... is phylogenetically conserved.
@en
P2093
P2860
P50
P1433
P1476
Antibody light-chain-restricte ...... is phylogenetically conserved.
@en
P2093
Christina Stolarchuk
David Easterhoff
Faruk Sinangil
Frederick H Jaeger
Georgia D Tomaras
Hua-Xin Liao
Jaranit Kaewkungwal
Kevin Wiehe
Krissey E Lloyd
P2860
P304
P356
10.1016/J.IMMUNI.2014.11.014
P407
P50
P577
2014-11-29T00:00:00Z